NCT01020890

Brief Summary

The purpose of this study is to provide data on the gastroesophageal reflux disease (GERD) prevalence as percentage of patients with upper gastrointestinal (GI) symptoms that are identified with GERD using the Gerd-Q Questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,210

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2009

Shorter than P25 for all trials

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

November 25, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 26, 2009

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

July 12, 2010

Status Verified

July 1, 2010

Enrollment Period

5 months

First QC Date

November 25, 2009

Last Update Submit

July 9, 2010

Conditions

Keywords

GERD diagnosisGERD-QGERD patients' characteristicsGERD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary care clinic

You may qualify if:

  • Patients with upper gastrointestinal symptoms

You may not qualify if:

  • History of oesophageal, gastric or duodenal surgery
  • Current treatment with antiinflammatory drugs, including OTC
  • Current treatment with proton pump inhibitors ang H2-blockers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Research Site

Blagoevgrad, Bulgaria

Location

Research Site

Burgas, Bulgaria

Location

Research Site

Dobrich, Bulgaria

Location

Research Site

Pleven, Bulgaria

Location

Research Site

Plovdiv, Bulgaria

Location

Research Site

Rousse, Bulgaria

Location

Research Site

Sofia, Bulgaria

Location

Research Site

Stara Zagora, Bulgaria

Location

Research Site

Varna, Bulgaria

Location

Research Site

Veliko Tarnovo, Bulgaria

Location

Research Site

Vratsa, Bulgaria

Location

Research Site

Yambol, Bulgaria

Location

MeSH Terms

Conditions

Gastroesophageal Reflux

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 25, 2009

First Posted

November 26, 2009

Study Start

November 1, 2009

Primary Completion

April 1, 2010

Study Completion

April 1, 2010

Last Updated

July 12, 2010

Record last verified: 2010-07

Locations